30th Annual Conference on Mammography and Other Breast Imaging - 2018

Dates and Times

Start: 9/29/2018 7:00 AM
End: 9/29/2018 5:00 PM

Objectives

• Recount the positive outcomes that have been identified in studies with DBT technology.
• Outline the potential roadblocks to adopting DBT technology.
• List the advantages of DBT in various clinical situations.
• Summarize the Breast Density law and its effect on screening recommendations.
• Discuss the advantages of adjunct ultrasound in addition to mammography in women with dense breasts.
• Describe the advantages and disadvantages to both HHUS and ABUS.
• Recognize the subtle imaging finding of asymmetries and architectural distortion at mammography.
• Apply imaging algorithm in evaluating mammographic asymmetries and architectural distortion.
• Correlate pathology with the imaging findings of mammographic asymmetries and architectural distortion.
• Recognize common causes of breast problems in stated population.
• Appropriately manage a young diagnostic patient, by identifying which modalities are most appropriate for this population.
• Detect the most common breast abnormalities found in younger patients, both male and female.
• Define inflammatory breast cancer.
• Evaluate the extent of disease in inflammatory breast cancer.
• Recognize the differential diagnostic possibilities of inflammatory breast cancer.·
• Apply ultrasound in detecting and diagnosing multifocal or multicentric breast cancer.
• Stage regional nodal basins using ultrasound.
• Correlate locoregional staging information obtained using ultrasound with that obtained using mammography and other imaging techniques.
• Describe the incidence trends in recent years of Breast cancer in minorities.
• Elaborate upon the disparities in mortality rates, screening attendance, and incidence rates of minorities vs Caucasians.
• Provide possible explanations for the disparities in the races.
• Work-up clinical findings in the breast with imaging tests.
• Apply MRI in problem-solving of equivocal imaging findings.
• Solve some of the commonly encountered breast imaging challenges with combining of imaging modalities.
• Define what makes a woman considered “High Risk”.
• List the Current 2017 NCCN guidelines for High Risk screening.
• Identify new MRI protocols that are abbreviated and may be suited for screening.
• Outline the screening recommendations for High Penetrance Mutations according to updated NCCN guidelines.
• Summarize the screening recommendations for Moderate Penetrance Mutations according to updated NCCN guidelines.
• Outline the surveillance options for patients of varying levels of high risk.
• Use imaging in assessment of neoadjuvant therapy response.
• Recognize the relative strengths and limitations of various imaging modalities in assessment of neoadjuvant therapy response.
• Affect care of the neoadjuvant therapy breast cancer patient using imaging information.